Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Chronic Myelogenous Leukemia (CML): QD Dosing at Study Entry	22
Overall Study	STARTED	CML: BID Dosing at Study Entry	15
Overall Study	STARTED	Accelerated Phase CML: BID Dosing at Study Entry	5
Overall Study	STARTED	Myeloid Blast Phase CML: BID Dosing at Study Entry	4
Overall Study	COMPLETED	Chronic Myelogenous Leukemia (CML): QD Dosing at Study Entry	0
Overall Study	COMPLETED	CML: BID Dosing at Study Entry	0
Overall Study	COMPLETED	Accelerated Phase CML: BID Dosing at Study Entry	0
Overall Study	COMPLETED	Myeloid Blast Phase CML: BID Dosing at Study Entry	0
Overall Study	NOT COMPLETED	Chronic Myelogenous Leukemia (CML): QD Dosing at Study Entry	22
Overall Study	NOT COMPLETED	CML: BID Dosing at Study Entry	15
Overall Study	NOT COMPLETED	Accelerated Phase CML: BID Dosing at Study Entry	5
Overall Study	NOT COMPLETED	Myeloid Blast Phase CML: BID Dosing at Study Entry	4

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00978731/flow